Article info

Download PDFPDF
Extended report
ADJUVITE: a double-blind, randomised, placebo-controlled trial of adalimumab in early onset, chronic, juvenile idiopathic arthritis-associated anterior uveitis

Authors

  1. Correspondence to Professor Pierre Quartier, Pediatric Immunology-Hematology and Rheumatology Unit, Necker-Enfants Malades University hospital, Assistance Publique-Hopitaux de Paris, Paris 75015, France; pierre.quartier{at}nck.aphp.fr
View Full Text

Citation

Quartier P, Baptiste A, Despert V On behalf of the ADJUVITE Study Group, et al
ADJUVITE: a double-blind, randomised, placebo-controlled trial of adalimumab in early onset, chronic, juvenile idiopathic arthritis-associated anterior uveitis

Publication history

  • Received July 17, 2017
  • Revised November 24, 2017
  • Accepted November 29, 2017
  • First published December 23, 2017.
Online issue publication 
August 09, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.